CY2016028I2 - S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv - Google Patents

S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv

Info

Publication number
CY2016028I2
CY2016028I2 CY2016028C CY2016028C CY2016028I2 CY 2016028 I2 CY2016028 I2 CY 2016028I2 CY 2016028 C CY2016028 C CY 2016028C CY 2016028 C CY2016028 C CY 2016028C CY 2016028 I2 CY2016028 I2 CY 2016028I2
Authority
CY
Cyprus
Prior art keywords
mercaptoacetanilides
inhibitors
reverse transcription
hiv reverse
triazolyl
Prior art date
Application number
CY2016028C
Other languages
English (en)
Other versions
CY2016028I1 (el
Original Assignee
Ardea Biosciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardea Biosciences, Inc. filed Critical Ardea Biosciences, Inc.
Publication of CY2016028I1 publication Critical patent/CY2016028I1/el
Publication of CY2016028I2 publication Critical patent/CY2016028I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Pens And Brushes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
CY2016028C 2004-08-25 2016-08-10 S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv CY2016028I2 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60422004P 2004-08-25 2004-08-25
US60421904P 2004-08-25 2004-08-25
US68635105P 2005-05-31 2005-05-31
EP05790722A EP1789039B1 (en) 2004-08-25 2005-08-25 S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase

Publications (2)

Publication Number Publication Date
CY2016028I1 CY2016028I1 (el) 2016-12-14
CY2016028I2 true CY2016028I2 (el) 2016-12-14

Family

ID=36000576

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20121100023T CY1112221T1 (el) 2004-08-25 2012-01-11 S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv
CY2016028C CY2016028I2 (el) 2004-08-25 2016-08-10 S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20121100023T CY1112221T1 (el) 2004-08-25 2012-01-11 S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv

Country Status (32)

Country Link
US (8) US7947721B2 (el)
EP (5) EP2433633A1 (el)
JP (2) JP4952943B2 (el)
KR (1) KR101241716B1 (el)
CN (2) CN101083987B (el)
AT (2) ATE540677T1 (el)
AU (2) AU2005280130C9 (el)
BR (2) BRPI0514630B8 (el)
CA (1) CA2578068C (el)
CY (2) CY1112221T1 (el)
DK (1) DK2135608T3 (el)
EA (2) EA015846B1 (el)
EC (1) ECSP077322A (el)
ES (2) ES2380604T3 (el)
FR (1) FR16C0031I2 (el)
HK (1) HK1133582A1 (el)
HR (1) HRP20130075T1 (el)
HU (1) HUS1600034I1 (el)
IL (3) IL181523A (el)
IN (1) IN2014CN03762A (el)
LT (1) LTC2135608I2 (el)
LU (1) LU93169I2 (el)
ME (1) ME01512B (el)
MX (1) MX2007002236A (el)
NL (1) NL300825I2 (el)
NZ (2) NZ581376A (el)
PL (1) PL2135608T3 (el)
PT (1) PT2135608E (el)
RS (1) RS52632B (el)
SG (2) SG155246A1 (el)
SI (1) SI2135608T1 (el)
WO (1) WO2006026356A2 (el)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015846B1 (ru) * 2004-08-25 2011-12-30 Ардеа Байосайенсиз, Инк. 2-[5-бром-4-(4-циклопропилнафталин-1-ил)-4н-[1,2,4]триазол-3-илсульфанил]уксусная кислота и ее метиловый эфир
WO2007050087A1 (en) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
KR101542629B1 (ko) 2007-05-30 2015-08-06 에프. 호프만-라 로슈 아게 비-뉴클레오사이드 역전사효소 억제제
WO2009030996A1 (en) * 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
NZ601774A (en) * 2007-11-27 2013-07-26 Ardea Biosciences Inc Substituted diazole and triazole compounds and compositions and methods of use
US8173690B2 (en) * 2008-09-04 2012-05-08 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
AU2009289647C1 (en) * 2008-09-04 2013-03-21 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
US8242154B2 (en) 2008-09-04 2012-08-14 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
AR073964A1 (es) * 2008-10-24 2010-12-15 Ardea Biosciences Inc Composiciones que comprenden acido 4-(2-(5-bromo-4-(1-ciclopropilnaftalen -4-il) -4h- 1,2,4-triazol-3-il tio ) acetamido)-3-clorobenzoico y sus sales farmaceuticamente aceptables y metodos de preparacion y uso delos mismos
WO2010048592A1 (en) * 2008-10-24 2010-04-29 Ardea Biosciences, Inc. Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
EP2432468A2 (en) 2009-05-20 2012-03-28 Ardea Biosciences, Inc. Methods of modulating uric acid levels
CN102040546B (zh) * 2009-10-10 2014-10-15 台州市华南医化有限公司 一种4-环丙基-1-异硫氰基萘的制备方法及中间体4-环丙基-1-萘甲醛肟/卤化物
NZ600984A (en) * 2010-01-08 2013-10-25 Ardea Biosciences Inc Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof
WO2011126852A2 (en) 2010-03-30 2011-10-13 Ardea Biosciences, Inc. Treatment of gout
CA2802407C (en) 2010-06-15 2018-01-23 Ardea Biosciences, Inc. Treatment of gout and hyperuricemia
US9212135B2 (en) 2010-06-16 2015-12-15 Ardea Biosciences, Inc. Phenylthioacetate compounds, compositions and methods of use
AR081930A1 (es) 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
CN101899013B (zh) * 2010-07-12 2012-07-25 山东大学 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用
CN103249417A (zh) * 2010-10-15 2013-08-14 阿迪亚生命科学公司 用于治疗高尿酸血症及相关疾病的方法
DK2658846T3 (en) 2010-12-30 2017-02-13 Ardea Biosciences Inc POLYMORPHE FORMS OF 2- (5-BROMO-4- (4-CYCLOPROPYLNAPHTHALEN-1-YL) -4H-1,2,4-TRIAZOL-3-YLTHIO) ACETIC ACID AND APPLICATIONS THEREOF
KR101988066B1 (ko) 2011-11-03 2019-09-27 아디아 바이오사이언스즈 인크. 3,4-이치환된 피리딘 화합물, 이의 사용 방법 및 이를 포함하는 조성물
AR091651A1 (es) * 2012-07-03 2015-02-18 Ardea Biosciences Inc Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico
CN105263913B (zh) * 2013-06-14 2017-12-15 广东东阳光药业有限公司 硫代1,2,4‑三唑衍生物及其制备方法
CN103524440B (zh) * 2013-10-15 2015-09-09 苏州鹏旭医药科技有限公司 痛风治疗药Lesinurad的制备方法及Lesinurad中间体
EP3071554B1 (en) * 2013-11-22 2018-10-03 Crystal Pharmatech Co., Ltd. Crystalline forms of lesinurad
CN104557748A (zh) * 2014-01-25 2015-04-29 广东东阳光药业有限公司 硫代-1,2,4-三唑衍生物的新的固体形态
CN105315218A (zh) * 2014-07-17 2016-02-10 天津药物研究院 一种制备lesinurad中间体1-萘基三唑硫酮的方法
CN104341363B (zh) * 2014-10-27 2016-08-17 张远强 一种硝基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104370842B (zh) * 2014-10-27 2016-07-13 张远强 苯基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104327000B (zh) * 2014-10-27 2016-08-17 张远强 苯基取代的三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104326993B (zh) * 2014-10-27 2016-08-17 张远强 一种硝基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104341361B (zh) * 2014-10-27 2017-01-11 张远强 一种腈基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104370841B (zh) * 2014-10-27 2016-07-13 张远强 三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104326998B (zh) * 2014-10-27 2016-08-17 张远强 苯基取代的三氮唑丙二酸类化合物、其制备方法及用途
CN104341362B (zh) * 2014-10-27 2016-07-13 张远强 三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104311498B (zh) * 2014-10-27 2016-04-06 张远强 烷氧基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
EP3112334A1 (en) 2015-06-29 2017-01-04 DPx Fine Chemicals Austria GmbH & CoKG Process for manufacturing 1-cyclopropyl-naphthalenes
CN104987311A (zh) * 2015-06-30 2015-10-21 安徽万邦医药科技有限公司 一种[4-(4-环丙基萘-1-基)-5-硝基- 4h-[1,2,4]三唑-3-基硫烷基]-乙酸乙酯的制备方法及其中间体(5-硝基-4h-[1,2,4]三唑-3-基硫基)-乙酸乙酯
CN105017168A (zh) * 2015-07-01 2015-11-04 安徽万邦医药科技有限公司 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法
CN105153056A (zh) * 2015-07-01 2015-12-16 安徽万邦医药科技有限公司 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法
WO2017036884A1 (en) 2015-08-28 2017-03-09 Sandoz Ag A lesinurad, free form / lesinurad ethyl ester co-crystal
CN105566237B (zh) * 2016-03-01 2018-05-18 山东大学 一种治疗痛风的三唑巯乙酸类化合物的制备方法
EP3473617B1 (en) * 2016-06-17 2022-09-07 Medshine Discovery Inc. Halogenated compound and axially chiral isomers thereof
EP3281941B1 (en) 2016-08-11 2019-07-24 Zentiva K.S. Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
EP3372592A1 (en) 2017-03-07 2018-09-12 Zentiva, k.s. Solid forms of lesinurad amine salts
US10351537B2 (en) * 2017-03-10 2019-07-16 Apotex Inc. Processes for the preparation of lesinurad and intermediates thereof
EP3315494A1 (en) 2017-04-19 2018-05-02 Química Sintética, S.A. Amorphous form of lesinurad and processes for its preparation
CN108947919B (zh) 2017-05-17 2023-05-02 上海奥博生物医药股份有限公司 一种抗痛风药Lesinurad的新型制备方法及其关键中间体
WO2019001325A1 (zh) * 2017-06-28 2019-01-03 苏州科睿思制药有限公司 雷西纳得的晶型xv及其制备方法
EP3498697A1 (en) 2017-12-12 2019-06-19 Química Sintética, S.A. Novel salts and polymorphs of lesinurad
WO2022249788A1 (ja) 2021-05-28 2022-12-01 住友化学株式会社 シクロアルキルブロミドの製造方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009A (en) * 1841-03-18 Improvement in machines for boring war-rockets
US2006A (en) * 1841-03-16 Clamp for crimping leather
US226186A (en) 1880-04-06 Car-coupling
US2008A (en) * 1841-03-18 Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
JPS5641637B2 (el) 1973-11-26 1981-09-29
US6832996B2 (en) * 1995-06-07 2004-12-21 Arthrocare Corporation Electrosurgical systems and methods for treating tissue
JPH07215940A (ja) 1994-01-27 1995-08-15 Torii Yakuhin Kk 抗ウイルス活性を有する化合物
US6245817B1 (en) * 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
WO1998035957A1 (en) 1997-02-14 1998-08-20 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
JPH10243033A (ja) * 1997-02-28 1998-09-11 Oki Electric Ind Co Ltd 復調装置
ES2361146T3 (es) * 1998-03-27 2011-06-14 Janssen Pharmaceutica Nv Derivados de la piramidina inhibitatoria de vih.
CN1178941C (zh) 1998-11-12 2004-12-08 纽罗克里恩生物科学有限公司 Crf受体拮抗剂以及与其有关的方法
WO2000037471A1 (en) * 1998-12-23 2000-06-29 Neurogen Corporation 2-amino-9-alkylpurines: gaba brain receptor ligands
CA2353961A1 (en) * 1998-12-25 2000-07-06 Shionogi & Co., Ltd. Heteroaromatic derivatives having an inhibitory activity against hiv integrase
US6593077B2 (en) * 1999-03-22 2003-07-15 Special Materials Research And Technology, Inc. Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate
MXPA03007883A (es) 2001-03-02 2003-12-04 Smithkline Beecham Corp Benzofenonas como inhibidores de transcriptasa inversa.
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
EP1505968A1 (en) 2002-05-13 2005-02-16 Eli Lilly And Company Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
CN1697650B (zh) 2002-08-23 2010-11-10 阿迪亚生命科学公司 非核苷类逆转录酶抑制剂
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
CL2004000192A1 (es) 2003-02-07 2005-03-18 Janssen Pharmaceutica Nv Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja.
DE602004031641D1 (de) 2003-09-25 2011-04-14 Janssen Pharmaceutica Nv Die replikation von hiv hemmende purinderivate
US20080031901A1 (en) * 2004-09-24 2008-02-07 Abbott Laboratories Sustained release monoeximic formulations of opioid and nonopioid analgesics
US7517998B2 (en) 2004-06-01 2009-04-14 Boehringer Ingelheim International Gmbh Non nucleoside reverse transcriptase inhibitors
WO2007050087A1 (en) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
EA015846B1 (ru) 2004-08-25 2011-12-30 Ардеа Байосайенсиз, Инк. 2-[5-бром-4-(4-циклопропилнафталин-1-ил)-4н-[1,2,4]триазол-3-илсульфанил]уксусная кислота и ее метиловый эфир
NZ601774A (en) * 2007-11-27 2013-07-26 Ardea Biosciences Inc Substituted diazole and triazole compounds and compositions and methods of use
AR073964A1 (es) 2008-10-24 2010-12-15 Ardea Biosciences Inc Composiciones que comprenden acido 4-(2-(5-bromo-4-(1-ciclopropilnaftalen -4-il) -4h- 1,2,4-triazol-3-il tio ) acetamido)-3-clorobenzoico y sus sales farmaceuticamente aceptables y metodos de preparacion y uso delos mismos
WO2010048592A1 (en) 2008-10-24 2010-04-29 Ardea Biosciences, Inc. Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
TWM377707U (en) * 2009-09-16 2010-04-01 Nat Energy Technology Co Ltd Assembly of power supply

Also Published As

Publication number Publication date
ECSP077322A (es) 2007-04-26
US20150094284A1 (en) 2015-04-02
HK1133582A1 (en) 2010-04-01
US8946273B2 (en) 2015-02-03
IL181523A (en) 2013-12-31
WO2006026356A2 (en) 2006-03-09
AU2005280130B2 (en) 2009-09-10
FR16C0031I2 (fr) 2017-03-31
BRPI0520870B8 (pt) 2021-05-25
EP2433633A1 (en) 2012-03-28
EA015846B1 (ru) 2011-12-30
LTC2135608I2 (lt) 2017-07-25
DK2135608T3 (da) 2012-01-23
JP5457472B2 (ja) 2014-04-02
IL201546A (en) 2013-10-31
KR101241716B1 (ko) 2013-03-08
NZ581376A (en) 2011-05-27
US8481581B2 (en) 2013-07-09
CA2578068C (en) 2011-08-09
US20120283301A1 (en) 2012-11-08
ME01512B (me) 2014-04-20
CY2016028I1 (el) 2016-12-14
BRPI0520870B1 (pt) 2020-11-10
SI2135608T1 (sl) 2012-03-30
AU2009217458A1 (en) 2009-10-15
BRPI0514630B8 (pt) 2021-05-25
CN101083987B (zh) 2011-01-26
CA2578068A1 (en) 2006-03-09
ES2380604T3 (es) 2012-05-16
EP2135608A1 (en) 2009-12-23
AU2009217458B2 (en) 2009-11-19
JP2012077088A (ja) 2012-04-19
NL300825I2 (el) 2017-01-24
CN101817793A (zh) 2010-09-01
US20180002296A1 (en) 2018-01-04
LTPA2016024I1 (lt) 2016-09-12
EP2135608B1 (en) 2011-10-12
PL2135608T3 (pl) 2012-07-31
NZ553534A (en) 2010-10-29
US20100069645A1 (en) 2010-03-18
CN101083987A (zh) 2007-12-05
FR16C0031I1 (el) 2016-09-23
AU2009217458A8 (en) 2009-10-29
EP2402011B1 (en) 2012-11-14
SG185992A1 (en) 2012-12-28
LU93169I2 (fr) 2016-10-10
US20110190491A1 (en) 2011-08-04
AU2005280130C1 (en) 2010-02-18
US20110313157A1 (en) 2011-12-22
EA200700488A1 (ru) 2007-08-31
IN2014CN03762A (el) 2015-09-25
CY1112221T1 (el) 2015-12-09
US7947721B2 (en) 2011-05-24
CN101817793B (zh) 2014-01-08
IL181523A0 (en) 2007-07-04
IL219131A0 (en) 2012-06-28
PT2135608E (pt) 2012-01-13
US20100267724A2 (en) 2010-10-21
JP4952943B2 (ja) 2012-06-13
WO2006026356A3 (en) 2006-08-10
KR20070054694A (ko) 2007-05-29
EP2135608B8 (en) 2012-03-21
AU2005280130C9 (en) 2010-03-04
ES2374773T3 (es) 2012-02-21
EP1789039B1 (en) 2012-01-11
HUS1600034I1 (hu) 2016-09-28
ATE540677T1 (de) 2012-01-15
US20100081827A1 (en) 2010-04-01
JP2008510828A (ja) 2008-04-10
EA200901186A1 (ru) 2010-04-30
EP2609917A1 (en) 2013-07-03
US8252828B2 (en) 2012-08-28
SG155246A1 (en) 2009-09-30
MX2007002236A (es) 2007-07-09
EA014737B1 (ru) 2011-02-28
EP1789039A2 (en) 2007-05-30
EP1789039A4 (en) 2009-08-05
AU2005280130A1 (en) 2006-03-09
RS52632B (en) 2013-06-28
US20080176850A1 (en) 2008-07-24
EP2402011A1 (en) 2012-01-04
BRPI0514630B1 (pt) 2020-09-15
US8003681B2 (en) 2011-08-23
BRPI0514630A (pt) 2008-06-17
HRP20130075T1 (hr) 2013-02-28
ATE528001T1 (de) 2011-10-15

Similar Documents

Publication Publication Date Title
CY2016028I1 (el) S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv
LTC1761540I2 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
CY2013042I1 (el) Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
CY2014012I1 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DK1720866T3 (da) Fremgangsmåde
NO20161397A1 (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer
ATE459624T1 (de) Inhibitoren der reversen transkriptase des hiv
ATE461202T1 (de) Hiv-integrasehemmer
CR10693A (es) Enantiomerically pure phosphoindoles as hiv inhibitors
DK1898903T3 (da) Inhibitorer af Akt-aktivitet
DK1962830T3 (da) Azaindolhæmmere af aurorakinaser.
DK2402317T3 (da) DGAT-inhibitor
DK1586319T3 (da) Thiadiazolidinoner som GSK-3-inhibitorer
DK2015754T3 (da) Anvendelse af dpp-iv-inhibitorer
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DE602005019971D1 (de) Inhibitoren von cysteinprotease
ATE452631T1 (de) N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer
DK1718608T3 (da) Virale polymeraseinhibitorer
DK1802872T3 (da) Rörledning
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
ATE420076T1 (de) Indozolonderivate als 11b-hsd1-inhibitoren
DK1948643T3 (da) 3-Alkyl-5-(4-alkyl-5-oxo-tetrahydrofuran-2-yl)pyrrolidin-2-on-derivater som mellemprodukter i syntese af renininhibitorer
DK1999133T3 (da) Fremgangsmåde til fremstilling af HIV-proteaseinhibitorer
FI20050195A (fi) Metalliseoksen käyttö